CCL Products Financial Statements

CCL Products (CCL) reported revenue of ₹31.14B in FY2025 with net income of ₹3.10B. Total assets stood at ₹42.41B and free cash flow was -₹1.28B.

CCL Products Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Revenue		12.46B	14.66B	20.74B	26.60B	31.14B
Cost of Rev. Cost of Revenue		-5.90B	-7.23B	-11.30B	-15.52B	-18.43B
Gross Profit		6.56B	7.43B	9.45B	11.08B	12.72B
SGA Sales, General & Admin		-3.55B	-4.08B	-5.42B	-6.56B	-7.08B
Op. Income Operating Income		2.52B	2.78B	3.39B	3.54B	4.65B
PBT Profit Before Tax		2.35B	2.61B	3.05B	2.76B	3.52B
Net Income		1.82B	2.04B	2.69B	2.50B	3.10B
Dil. Shares Diluted Shares		133.03M	133.03M	133.03M	133.29M	133.42M
Diluted EPS		13.70	15.36	20.21	18.76	23.26

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows CCL Products's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

CCL Products Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Curr. assets Total current assets		7.91B	9.91B	12.47B	17.41B	20.88B
Non-curr. assets Total non-current assets		9.97B	10.79B	13.50B	17.95B	21.53B
Total assets		17.88B	20.70B	25.97B	35.36B	42.41B
Curr. liabilities Total current liabilities		4.69B	6.30B	8.35B	12.77B	16.37B
Non-curr. liab. Total non-current liabilities		2.32B	1.89B	2.65B	5.85B	6.37B
Total liabilities		7.01B	8.19B	11.00B	18.62B	22.74B
Total equity		10.87B	12.51B	14.97B	16.74B	19.67B
Total liab. & eq. Total liabilities & equity		17.88B	20.70B	25.97B	35.36B	42.41B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures CCL Products's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

CCL Products Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Net Income		2.35B	2.61B	3.05B	2.76B	3.52B
Operating CF Cash flow Operating Activities		1.71B	1.16B	1.98B	553.78M	2.90B
Capex Investments in PPE		-1.55B	-1.90B	-3.32B	-5.13B	-4.18B
Investing CF Cash flow Investing Activities		-1.53B	-1.92B	-3.32B	-5.14B	-4.16B
Dividend Paid		-266.06M	-665.14M	-665.14M	-665.14M	-267.06M
Financing CF Cash flow Financing Activities		636.27M	87.05M	1.64B	5.59B	530.02M
Cash (start) Cash at beginning of period		376.54M	1.19B	527.81M	825.99M	1.69B
Cash (end) Cash at end of period		1.19B	527.81M	825.99M	1.69B	969.43M
FCF Free Cash Flow		162.19M	-736.71M	-1.34B	-4.58B	-1.28B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how CCL Products's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025